Transforming near-patient testing with central lab precision test results in under 5 minutes
In response to the current COVID-19 pandemic, Prominex is accelerating its plans for a rapid SARS-CoV-2 test on its Prominex point-of-care molecular diagnostic platform and a high-throughput SARS-CoV-2 assay for the laboratory market.
“We are committed to providing solutions needed in the market today in the fight against COVID-19. Our SARS-CoV-2 products can deliver accurate results in as early as 5 minutes aiding healthcare professionals with efficient treatment and infection control decisions. Our lab focused SARS-CoV-2 assay will have one of the highest daily testing capacities to help aid in national testing capacity limitations many labs are experiencing.”
-Paul Thomas, CEO